Angiotensin II blocks hippocampal long-term potentiation

Brain Res. 1991 Dec 20;567(2):321-4. doi: 10.1016/0006-8993(91)90812-a.

Abstract

We have found that injection of angiotensin II (AII) above the hippocampus in the intact rat blocks the induction of long-term potentiation (LTP) in perforant path-stimulated dentate granule cells. A minimum dose of 4.78 pmol AII was required for the complete blockade of LTP and this blockade was entirely prevented if the AII-specific antagonist saralasin was co-injected at a 50-fold molar excess. AII thus appears to act via AII receptors and does not cause non-specific inhibition. The injection of saralasin alone yielded LTP comparable to that obtained when vehicle was injected. Angiotensin III was found to be 40-50 fold less potent than AII in blocking LTP. Both AII and AII receptors of unknown function occur in the hippocampal formation. The results reported here suggest a role for these molecules in the control of hippocampal LTP.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Angiotensin II / metabolism
  • Angiotensin II / pharmacology*
  • Angiotensin III / pharmacology
  • Animals
  • Evoked Potentials / drug effects
  • Evoked Potentials / physiology
  • Hippocampus / drug effects
  • Hippocampus / physiology*
  • In Vitro Techniques
  • Molecular Sequence Data
  • Rats
  • Receptors, Angiotensin / drug effects
  • Receptors, Angiotensin / metabolism
  • Saralasin / pharmacology

Substances

  • Receptors, Angiotensin
  • Angiotensin II
  • Angiotensin III
  • Saralasin